AEON Biopharma, Inc.
No SEC Form 4 filings for $AEON in the last 30 days.
See all $AEON insider activity →AEON Biopharma reported Q2 results showing its net loss narrowed, helped by gains from warrants, according to the company. The firm also said its cash runway has been extended, citing improved liquidity. The update provides investors with a view of near-term funding and operating performance.
AEON Biopharma, Inc. (AEON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 aeon-20260812xex99d1.htm EX-99.1 Exhibit 99.1 PRESS RELEASE AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Executed a $15.3 million financing with milestone warrants providing potential for an additional $34.0 million in gro
Aeon, the Japanese retailer, is exiting its Thailand supermarket business after more than four decades, according to the report. It is selling the unit to Central Group, citing pressure on consumption from a slowing economy. Aeon says it will shift its regional growth focus toward Vietnam.
Over the past 7 days, alphai's AI scored 3 news stories mentioning AEON (AEON Biopharma, Inc.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent AEON coverage spans financial news, earnings and mergers & acquisitions.
Warrant-related gains narrowing the net loss and an extended cash runway reduce near-term liquidity risk, but the runway extension is the more actionable driver for risk premium.
Near-term catalyst is FDA feedback timing plus incremental funding runway into 1Q 2027; dilution risk is tied to milestone warrants.
Thailand exit reduces regional retail exposure, while Vietnam focus may shift earnings mix and execution risk.
AEON Thailand exits the supermarket business, shifting capital and strategy toward Vietnam retail expansion.
As the seller, AEON (Thailand) faces deal-driven exit/ownership change risk, but the article provides limited deal economics and no closing timeline.
alphai scores every news story that mentions AEON with an AI model for sentiment and relevance, and aggregates insider trades from AEON Biopharma, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
AEON Biopharma reported Q2 results showing its net loss narrowed, helped by gains from warrants, according to the company. The firm also said its cash runway has been extended, citing improved liquidity. The update provides investors with a view of near-term funding and operating performance.
2 min readAEON Biopharma, Inc. (AEON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 aeon-20260812xex99d1.htm EX-99.1 Exhibit 99.1 PRESS RELEASE AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Executed a $15.3 million financing with milestone warrants providing potential for an additional $34.0 million in gro
6 min readAeon, the Japanese retailer, is exiting its Thailand supermarket business after more than four decades, according to the report. It is selling the unit to Central Group, citing pressure on consumption from a slowing economy. Aeon says it will shift its regional growth focus toward Vietnam.
2 min readCentral Retail said its unit Central Food Retail will acquire all AEON (Thailand) ordinary shares, after signing an agreement filed Aug. 7. Completion is expected Sept. 30. MaxValu stores will be rebranded as Tops and integrated. AEON exits Thai supermarkets after 40+ years, while prioritizing Vietnam, where AEON Mall reported FY2024 revenue of about 17.3bn yen (+14%).
5 min readCentral Retail Corporation (CRC) said, in a Stock Exchange of Thailand filing, that its unit Central Food Retail (CFR) will buy AEON (Thailand) Co Ltd, which operates 30 MaxValu supermarkets and has 890 million baht registered capital. CRC plans to fund the deal with internal cash flow, rebrand stores as Tops, and add 900,000+ customers, plus land and a ready-to-eat processing center.
4 min readAEON Credit Service (M) Bhd said in its first-quarter 2027 results that younger and lower-income borrowers face higher financial stress, especially in personal and used-car financing. The company deployed AI voice bots to automate repayment follow-ups for lower-risk customers. Net profit was RM95.16m (+22.7% YoY), with non-performing loans at 2.6% and receivables write-offs at 1.4%.
3 min readAnalysts issued multiple rating changes. Humana (HUM) was upgraded by Leerink to Outperform with a $513 target and by Piper Sandler to Overweight with a $463 target. Bloom Energy (BE), Sprouts (SFM), uniQure (QURE), and Core Scientific (CORZ) also saw upgrades. Las Vegas Sands (LVS) was downgraded to Hold by Argus. Other actions included P&G (PG), SiteOne (SITE), Capricor (CAPR), and Fannie Mae (FNMA).
3 min readReuters reports a 7.1-magnitude earthquake in southern Japan killed at least 13 people and left thousands without power. Rescuers pulled eight survivors from a partially collapsed Aeon mall near Kumamoto, with three deaths and four workers unaccounted for; authorities are investigating a possible gas explosion. Nippon Paper Industries reported missing workers at a factory, and companies including Renesas, Sony, Tokyo Electron, Honda, and Toyota suspended operations.
4 min readNichirei Corp said a system failure tied to unauthorized access began disrupting its frozen food shipments and refrigerated warehouse operations. The company, serving about 5,000 business clients, plans a gradual restart from Friday but gave no full recovery timeline and flagged possible personal data exposure. KFC Japan, Kura Sushi, Aeon subsidiaries, Don Quijote operator Pan Pacific, Ezaki Glico, and Imuraya reported ingredient shortages.
3 min readAEON Biopharma, Inc. (AEON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-4.4 6 aeon-20260713xex4d4.htm EX-4.4 M2561538.DOC;3 Exhibit 4.4 EXECUTION VERSION WARRANT AGENCY AGREEMENT THIS WARRANT AGENCY AGREEMENT (this “Agreement”), dated as of July 15, 2026, is entered into by and between AEON Biopharma, Inc., a Delaware corporation (the “Company”),
2 min read
